GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Willow Biosciences Inc (TSX:WLLW) » Definitions » Change In Working Capital

Willow Biosciences (TSX:WLLW) Change In Working Capital : C$1.38 Mil (TTM As of Sep. 2024)


View and export this data going back to 1983. Start your Free Trial

What is Willow Biosciences Change In Working Capital?

Willow Biosciences's change in working capital for the quarter that ended in Sep. 2024 was C$-0.12 Mil.

Willow Biosciences's change in working capital for the fiscal year that ended in Dec. 2023 was C$-0.21 Mil.

It is calculated by adding the items under "Change in operating assets and liabilities" (may refer to a different name for different company) section in Cash Flow Statement. Not by calculating the number changes in each periods' working capital (Total Current Assets minus Total Current Liabilities).

Willow Biosciences Change In Working Capital Historical Data

The historical data trend for Willow Biosciences's Change In Working Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Willow Biosciences Change In Working Capital Chart

Willow Biosciences Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Dec19 Dec20 Dec21 Dec22 Dec23
Change In Working Capital
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.35 -0.21 -0.32 0.13 -0.21

Willow Biosciences Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Change In Working Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.31 0.85 0.19 0.46 -0.12

Willow Biosciences Change In Working Capital Calculation

Change In Working Capital for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$1.38 Mil.

Working Capital is a measure of a company's short term liquidity or its ability to cover short term liabilities. It is defined as the difference between a company's current assets and current liabilities.

Changes in Working Capital is reported in the cash flow statement since it is one of the major ways in which net income can differ from operating cash flow. It is calculated by adding the items under "Change in operating assets and liabilities" (may refer to a different name for different company) section in Cash Flow Statement.

Use Wal-Mart Stores Inc (Jan 2014, Annual Data) as an example: Source: Wal-Mart Stores Inc 2014-01-31 10-K from SEC

Consolidated Statements of Cash Flows Fiscal Years EndedJanuary 31,(Amounts in millions)
Cash flows from operating activities: 2014 2013 2012
Changes in certain assets and liabilities, net of effects of acquisitions:
Receivables, net (566) (614) (796)
Inventories (1,667) (2,759) (3,727)
Accounts payable 531 1,061 2,687
Accrued liabilities 103 271 (935)
Accrued income taxes (1,224) 981 994

For 2014-01-31, add all the items under 2014 collum together, Change in Working Capital was (566) + (1,667) + 531 + 103 + (1,224) = $ (2,823) Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Willow Biosciences Change In Working Capital Related Terms

Thank you for viewing the detailed overview of Willow Biosciences's Change In Working Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Willow Biosciences Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Willow Biosciences Inc (TSX:WLLW) » Definitions » Change In Working Capital
Comparable Companies
XCNQ:IMCC XCNQ:OILS TSX:CTX XCNQ:MVMD NEOE:FH TSXV:PCLO TSXV:MPH XCNQ:PWR XCNQ:RIV TSXV:VM ZTS XTER:MRK NSE:SUNPHARMA LSE:HLN TSE:4502 XSWX:GALD XSWX:SDZ XTAE:TEVA NSE:DIVISLAB VTRS
Traded in Other Exchanges
CANSF:USA
Address
202, 1201 5th Street SW, Calgary, AB, CAN, T2R 0Y6
Website
https://www.willowbio.com
Willow Biosciences Inc is a Canadian biotechnology company. It has only one reportable segment engaged in developing and producing high-purity, plant-derived ingredients for consumer care, food and beverage, and pharmaceutical products. It has a geographic presence in Canada and the United states, in which it generates the majority of its revenue from the United states.
Executives
Christopher Kenneth Savile Director, Senior Officer
Travis Doupe Senior Officer
Patricia Ranija Choudhary Director
Sadiq Lalani Director
Barbara Elaine Munroe Director
Peter Seufer-wasserthal Director
Trevor Anthony Peters Director, Senior Officer
Troy Tapan Talkkari Senior Officer

Willow Biosciences Headlines

No Headlines